We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

1 hedge funds and large institutions have $4 invested in Cyclo Therapeutics, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less capital invested

Capital invested by funds: $46.9K → $4 (-$46.9K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$36.7K
2
Citadel Advisors
Citadel Advisors
Florida
-$10.1K
3
UBS Group
UBS Group
Switzerland
-$67
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$4 -$67 -225 -92%
WVP
2
Worth Venture Partners
New Jersey
– -$36.7K -70,570 Closed
Citadel Advisors
3
Citadel Advisors
Florida
– -$10.1K -19,460 Closed

CYTHW Hedge Fund Activity: Q1 2023 in Review

1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q1 2023, worth a combined $4 — down 100% from $46.9K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CYTHW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Worth Venture Partners, exiting entirely with an estimated $36.7K sold.

  • 1 institutional investor held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q1 2023, down from 3 in Q4 2022.
  • Funds reported $4 of Cyclo Therapeutics, Inc. Warrant stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q1 2023 and 2 closed out, a net change of -2 holders.
  • The largest Cyclo Therapeutics, Inc. Warrant seller in Q1 2023 was Worth Venture Partners, an estimated $36.7K sold.

Based on aggregated 13F filings for Q1 2023.